News Detail
Adelaide, Australia; 24 July 2023: One of the world’s largest studies on the impact of cholesterol-lowering medication has highlighted an issue with a new class of drugs that could impair lung function in some patients.
That’s the finding ......
View Details
Source : News Medical
Blood
Blood Pressure
Brain
Cardiovascular Disease
Cholesterol
Clinical Trial
Dementia
Depression
Diabetes
Diarrhoea
Drugs
Genetic
Genetic Information
Heart
High Blood Pressure
High Cholesterol
Hippocampus
Pharmacology
Testosterone
UK Biobank
Related News
- Cipla gets nod to market Afrezza insulin inhalation powder in India (12-12-2024)
- UK regulator probes anti-depressants safety alerts after suicide link (12-12-2024)
- Haryana Food Department to Crack Down on Fake Protein Supplements After Major Bust (12-12-2024)
- Drug inspector sentenced to 3-yr rigorous imprisonment (12-12-2024)
- 11.12 crore worth of short-shelf life medicines expired due to delayed supply to TNMSC: CAG Report (12-12-2024)
- Ayush Ministry amends D&C Act to add Homoeopathy, Sowa Rigpa books and Pharmacopoeias (12-12-2024)
- Construction of all three bulk drug parks are in progress: Ministry of chemicals (12-12-2024)
- Four-member gang nabbed for selling ‘Mephentermine Sulphate’ injections in Hyderabad (12-12-2024)
- Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)
- Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)